Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 1
2004 3
2005 1
2006 2
2007 2
2008 1
2009 2
2010 2
2011 2
2012 1
2013 2
2014 3
2015 9
2016 4
2017 14
2018 9
2019 6
2020 11
2021 6
2022 5
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Lancet. 2017 Sep 16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2. Lancet. 2017. PMID: 28919117 Free PMC article.
Ribonucleicacid interference or small molecule inhibition of Runx1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction.
Martin TP, MacDonald EA, Bradley A, Watson H, Saxena P, Rog-Zielinska EA, Raheem A, Fisher S, Elbassioni AAM, Almuzaini O, Booth C, Campbell M, Riddell A, Herzyk P, Blyth K, Nixon C, Zentilin L, Berry C, Braun T, Giacca M, McBride MW, Nicklin SA, Cameron ER, Loughrey CM. Martin TP, et al. Among authors: cameron er. Cardiovasc Res. 2023 Dec 19;119(16):2663-2671. doi: 10.1093/cvr/cvad107. Cardiovasc Res. 2023. PMID: 37433039 Free PMC article.
RUNX1: an emerging therapeutic target for cardiovascular disease.
Riddell A, McBride M, Braun T, Nicklin SA, Cameron E, Loughrey CM, Martin TP. Riddell A, et al. Among authors: cameron e. Cardiovasc Res. 2020 Jul 1;116(8):1410-1423. doi: 10.1093/cvr/cvaa034. Cardiovasc Res. 2020. PMID: 32154891 Free PMC article. Review.
Runx Genes in Breast Cancer and the Mammary Lineage.
Rooney N, Riggio AI, Mendoza-Villanueva D, Shore P, Cameron ER, Blyth K. Rooney N, et al. Among authors: cameron er. Adv Exp Med Biol. 2017;962:353-368. doi: 10.1007/978-981-10-3233-2_22. Adv Exp Med Biol. 2017. PMID: 28299668 Review.
RUNX2 in mammary gland development and breast cancer.
Ferrari N, McDonald L, Morris JS, Cameron ER, Blyth K. Ferrari N, et al. Among authors: cameron er. J Cell Physiol. 2013 Jun;228(6):1137-42. doi: 10.1002/jcp.24285. J Cell Physiol. 2013. PMID: 23169547 Review.
The Runx genes as dominant oncogenes.
Cameron ER, Blyth K, Hanlon L, Kilbey A, Mackay N, Stewart M, Terry A, Vaillant F, Wotton S, Neil JC. Cameron ER, et al. Blood Cells Mol Dis. 2003 Mar-Apr;30(2):194-200. doi: 10.1016/s1079-9796(03)00031-7. Blood Cells Mol Dis. 2003. PMID: 12732183 Review.
Oncogene-induced senescence: an essential role for Runx.
Kilbey A, Terry A, Cameron ER, Neil JC. Kilbey A, et al. Among authors: cameron er. Cell Cycle. 2008 Aug;7(15):2333-40. doi: 10.4161/cc.6368. Epub 2008 May 29. Cell Cycle. 2008. PMID: 18677118 Free PMC article. Review. No abstract available.
The RUNX genes: gain or loss of function in cancer.
Blyth K, Cameron ER, Neil JC. Blyth K, et al. Among authors: cameron er. Nat Rev Cancer. 2005 May;5(5):376-87. doi: 10.1038/nrc1607. Nat Rev Cancer. 2005. PMID: 15864279 Review.
95 results